Europe And Japan Allergy Immunotherapy Market, By Treatment, By Allergy Type, By Distribution Channel, By Geography

Description

Europe And Japan Allergy Immunotherapy Market is estimated to be valued at USD 1,675.6 Mn in 2026 and is expected to reach USD 2,894.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,675.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.40%	2033 Value Projection:	USD 2,894.4 Mn

Immunotherapy is a preventive treatment for allergic reactions which are caused by substances such as grass pollens, house dust mites and bee venom. While providing immunotherapy treatment to patients, the dose of the drug is gradually increased to which the person is allergic. Immunotherapy also reduces the inflammation that characterizes rhinitis and asthma. Allergy shots, also known as subcutaneous immunotherapy (SCIT), is the most commonly used immunotherapy and this is the only treatment available that actually changes the immune system, making it possible to prevent development of new allergies and asthma.

Market Dynamics

Market players are involved in research and development activities for development of drugs for allergy immunotherapy and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in May 2018, Stallergenes Greer, a biopharmaceutical company, announced positive results for its phase III clinical trial which was carried out, in order to evaluate the efficacy and safety of its sublingual allergy immunotherapy tablet STAGR320, for the treatment of house dust mite.

Key players are engaged in receiving approvals for their drugs, from the regulatory authorities and this is expected to drive growth of the Europe and Japan allergy immunotherapy market, over the forecast period. For instance, in November 2018, Stallergenes Greer, a biopharmaceutical company, received approval from the U.S. Food and Drug Administration (US FDA), for the extension of the indication for Oralair, for the treatment of patients with grass pollen-induced allergic rhinitis.

Moreover, in September 2018, Torii Pharmaceutical Co., Ltd. announced that Japan's Ministry of Health, Labour and Welfare had approved the New Drug Application (NDA) for the Japanese cedar sublingual allergy immunotherapy (SLIT) tablet, i.e, CEDARCURE.

Key features of the study

This report provides an in-depth analysis of the Europe and Japan allergy immunotherapy market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the Europe and Japan allergy immunotherapy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Novartis International AG, Merck & Co., Inc., Aimmune Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., HAL Allergy B.V., Stallergenes Greer, ALK-Abello A/S, Allergy Therapeutics Plc, Torii Pharmaceutical Co., Ltd., DESENTUM OY
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The Europe and Japan allergy immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe and Japan allergy immunotherapy market

Market Segmentation

By Treatment Insights (Revenue, US$ Mn, 2020 - 2033)
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type Size Insights (Revenue, US$ Mn, 2020 - 2033)
- Allergy Rhinitis
- Allergy Asthma
- Pollen Allergies
- Cedar
- Birch
- Oak
- Others
- Pet Allergy
- Cats
- Dogs
- Other Pets
- Birds Allergy
- Others
By Distribution Channel Insights (Revenue, US$ Mn, 2020 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region Insights (Revenue, US$ Mn, 2020 - 2033)
- Europe
- U.K.
- Germany
- Italy
- Spain
- Denmark
- Sweden
- Poland
- Belgium
- Netherlands
- Russia
- Rest of Europe
- Japan
Key Players
- ALK-Abello
- Stallergenes Greer
- HAL Allergy Group
- Allergy Therapeutics
- Aimmune Therapeutics
- DBV Technologies
- Torii Pharmaceutical
- ASIT Biotech
- Inmunotek
- Laboratorios LETI Pharma
- ROXALL Medizin
- Merck KGaA
- Kyowa Kirin
- Shionogi & Co.
- Novartis International AG

Product Code: CMI5037

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Allergy Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
- Regulatory Scenario
- Industry Trend
Merger and Acquisitions
Key Developments
Market Trends
Recent Product Launch / Approval
PEST Analysis
Merger, Acquisition & Agreements
Epidemiology
Porter's Five Force Analysis
Value Chain Analysis

4. Europe and Japan Allergy Immunotherapy Market, By Treatment, 2020 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)

5. Europe and Japan Allergy Immunotherapy Market, By Allergy Type, 2020 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Allergy Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
Allergy Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
Pollen Allergies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
  - Cedar
  - Birch
  - Oak
  - Others
Pet Allergies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
  - Cats
  - Dogs
  - Other Pets
Birds Allergy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Mn)

6. Europe and Japan Allergy Immunotherapy Market, By Distribution Channel, 2020 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, 2020 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2033, (US$ Million)

7. Europe and Japan Allergy Immunotherapy Market, By Region, 2020 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2020 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2020-2033
- Regional Trends
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2020 - 2033, (US$ Mn)
  - U.K.
  - Germany
  - Italy
  - Spain
  - Denmark
  - Sweden
  - Poland
  - Belgium
  - Netherlands
  - Russia
  - Rest of Europe
  - Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2020 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Allergy Type, 2020 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2033, (US$ Mn)

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- ALK-Abello
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Stallergenes Greer
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- HAL Allergy Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Allergy Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Aimmune Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- DBV Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Torii Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ASIT Biotech
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Inmunotek
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Laboratorios LETI Pharma
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- ROXALL Medizin
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Kyowa Kirin
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Shionogi & Co.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Novartis International AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
  - Analyst Views

9. Section

Research Methodology
About us